Boehringer Ingelheim and Click Therapeutics join hands for CT-155, digital therapeutic for schizophrenia Read more
Junshi Biosciences gets US FDA Breakthrough Therapy Designation for Toripalimab to treat nasopharyngeal carcinoma Read more
Informing payers and patients of biological therapy advantages can strengthen biosimilars market Read more